Developing as a significant advance in the fight against obesity, this medication is capturing considerable attention . This treatment combines properties of two recognized GLP-1 receptor agonists, liraglutide, plus an new glucose-dependent hormonal component. Early study results have indicated substantial weight decrease in individuals with exces